This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Hypertensive heart and/or renal disease
I9_HYPTENSHR
nephrosclerosis: Hardening of the walls of the small arteries and arterioles (small arteries that convey blood from arteries to the even smaller capillaries) of the kidney. This condition is caused by hypertension (high blood pressure)
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Hospital discharge: ICD-9
4029A|4029B|4039A|4040A
Hospital discharge: ICD-8
40299|40399|40499
Cause of death: ICD-9
4029A|4029B|4039A|4040A
Cause of death: ICD-8
40299|40399|40499
2 out of 7 registries used, show all original rules.
9856
Check minimum number of events None
9856
Remove individuals based on genotype QC
9529
I9_HYPTENSHR
Control definitions
Control exclude
I9_HYPERTENSION
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Hypertensive heart and/or renal disease
based on the number of shared cases.
Broader endpoints:
- Hypertension
- Hypertensive diseases
- Hypertensive diseases (excluding secondary)
- Gout-related co-morbidities
- Cardiovascular diseases (excluding rheumatic etc)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 9529 | 3706 | 5823 |
| Unadjusted prevalence (%) | 2.53 | 1.76 | 3.50 |
| Mean age at first event (years) | 66.84 | 68.52 | 65.77 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: I9_HYPTENSHR – Hypertensive heart and/or renal disease
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Hypertensive heart and/or renal disease
↥Endpoint not on priority list, no data to show.